PINK1 mutations are associated with sporadic early-onset parkinsonism
- PMID: 15349860
- DOI: 10.1002/ana.20256
PINK1 mutations are associated with sporadic early-onset parkinsonism
Abstract
We have recently reported homozygous mutations in the PINK1 gene in three consanguineous families with early-onset parkinsonism (EOP) linked to the PARK6 locus. To further evaluate the pathogenic role of PINK1 in EOP and to draw genotype-phenotype correlates, we performed PINK1 mutation analysis in a cohort of Italian EOP patients, mostly sporadic, with onset younger than 50 years of age. Seven of 100 patients carried missense mutations in PINK1. Two patients had two PINK1 mutations, whereas in five patients only one mutation was identified. Age at onset was in the fourth-fifth decade (range, 37-47 years). The clinical picture was characterized by a typical parkinsonian phenotype with asymmetric onset and rare occurrence of atypical features. Slow progression and excellent response to levodopa were observed in all subject. Two of 200 healthy control individuals also carried one heterozygous missense mutation. The identification of a higher number of patients (5%) than controls (1%) carrying a single heterozygous mutation, along with previous positron emission tomography studies demonstrating a preclinical nigrostriatal dysfunction in PARK6 carriers, supports the hypothesis that haploinsufficiency of PINK1, as well as of other EOP genes, may represent a susceptibility factor toward parkinsonism. However, the pathogenetic significance of heterozygous PINK1 mutations still remains to be clarified.
Similar articles
-
Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.BMC Neurol. 2008 Dec 16;8:47. doi: 10.1186/1471-2377-8-47. BMC Neurol. 2008. PMID: 19087301 Free PMC article.
-
Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism.Ann Neurol. 2004 Sep;56(3):427-31. doi: 10.1002/ana.20247. Ann Neurol. 2004. PMID: 15349871
-
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.Neurology. 2005 Jul 12;65(1):87-95. doi: 10.1212/01.wnl.0000167546.39375.82. Neurology. 2005. PMID: 16009891
-
Early-Onset Parkinsonism: Case Report and Review of the Literature.Pediatr Neurol. 2017 Feb;67:102-106.e1. doi: 10.1016/j.pediatrneurol.2015.06.005. Epub 2015 Oct 23. Pediatr Neurol. 2017. PMID: 28062148 Review.
-
Deciphering the role of heterozygous mutations in genes associated with parkinsonism.Lancet Neurol. 2007 Jul;6(7):652-62. doi: 10.1016/S1474-4422(07)70174-6. Lancet Neurol. 2007. PMID: 17582365 Review.
Cited by
-
Abnormal Development of Glutamatergic Synapses Afferent to Dopaminergic Neurons of the Pink1(-/-) Mouse Model of Parkinson's Disease.Front Cell Neurosci. 2016 Jun 23;10:168. doi: 10.3389/fncel.2016.00168. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27445695 Free PMC article.
-
Mitochondrial fission and mitophagy are independent mechanisms regulating ischemia/reperfusion injury in primary neurons.Cell Death Dis. 2021 May 12;12(5):475. doi: 10.1038/s41419-021-03752-2. Cell Death Dis. 2021. PMID: 33980811 Free PMC article.
-
Unveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression.PLoS One. 2012;7(9):e45535. doi: 10.1371/journal.pone.0045535. Epub 2012 Sep 21. PLoS One. 2012. PMID: 23029078 Free PMC article.
-
Pink1 kinase and its membrane potential (Deltaψ)-dependent cleavage product both localize to outer mitochondrial membrane by unique targeting mode.J Biol Chem. 2012 Jun 29;287(27):22969-87. doi: 10.1074/jbc.M112.365700. Epub 2012 Apr 30. J Biol Chem. 2012. PMID: 22547060 Free PMC article.
-
Genetics of Parkinson's disease.Cold Spring Harb Perspect Med. 2012 Jan;2(1):a008888. doi: 10.1101/cshperspect.a008888. Cold Spring Harb Perspect Med. 2012. PMID: 22315721 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases